Communiqués RxSight, Inc.

Actions

RXST

US78349D1072

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 17/07/2024			Varia. 5j.	Varia. 1 janv.
47,22 ^USD	-4,47 %		-7,61 %	+17,11 %

18/06	Un initié de RxSight a vendu des actions d'une valeur de 906 288 $, selon un récent dépôt auprès de la SEC	MT
21/05	Un initié de Rxsight a acheté des actions d'une valeur de 305 457 $, selon un récent dépôt auprès de la SEC	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

RxSight, Inc. To Participate in the Truist Securities Medtech Conference	05/06	GL
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares	13/05	GL
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares	13/05	AQ
RxSight, Inc. Announces Pricing of Public Offering of Common Stock	09/05	GL
RxSight, Inc. Announces Proposed Public Offering of Common Stock	08/05	GL
RxSight, Inc. Announces Proposed Public Offering of Common Stock	08/05	AQ
RxSight, Inc. Reports First Quarter 2024 Financial Results	06/05	GL
RxSight, Inc. Reports First Quarter 2024 Financial Results	06/05	AQ
RxSight, Inc. to Present at the Bank of America Healthcare Conference	01/05	GL
RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024	22/04	GL
RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting	04/04	GL
RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference	27/03	GL
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference	01/03	GL
RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference	01/03	AQ
RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results	28/02	GL
RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results	28/02	AQ
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	14/02	GL
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	14/02	AQ
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance	07/01	AQ
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance	07/01	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués RxSight, Inc.

Actions

RXST

US78349D1072

Communiqués

Filtres